Faes Farma SA header image

Faes Farma SA

FAE

Equity

ISIN ES0134950F36 / Valor 2837976

BME Bolsas y Mercados Espanoles - Renta Variable (2026-07-03)

EUR 4.63-0.43%

Faes Farma SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Faes Farma SA is a Spanish pharmaceutical group that develops, manufactures and distributes prescription and over‑the‑counter medicines and pharmaceutical ingredients, operating both finished‑product and active pharmaceutical ingredient (API) businesses. Listed on the Madrid stock exchange, the company combines research and development with industrial production at several manufacturing sites and sells into domestic and international markets — including Europe and Latin America — across hospital, primary‑care and consumer‑health channels. Its revenue mix reflects sales of branded and generic medicines, OTC products and chemical/API supply, supplemented by contract manufacturing and selective business development to expand its geographic and therapeutic footprint.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

3.00%1Y

44.7%3Y

37.1%5Y

Performance

20.0%1Y

19.5%3Y

20.0%5Y

Volatility

1649 M

Market cap (USD)

148,733

Daily traded volume (Shares)

3.47 / 3.405

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited Valor: 136422285

Annual Return

-50%0%+50%

Risk level

110

-0.94%INR 1,837.10

Rubicon Research Limited

Rubicon Research Limited Valor: 149582844

Annual Return

-50%0%+50%

Risk level

110

-5.22%INR 1,302.75

Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited Valor: 30691066

Annual Return

-50%0%+50%

Risk level

110

-0.37%INR 1,646.15

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc Valor: 115580129

Annual Return

-50%0%+50%

Risk level

110

1.78%USD 18.27

Healthcare Services Group Inc

Healthcare Services Group Inc Valor: 938239

Annual Return

-50%0%+50%

Risk level

110

0.16%USD 25.15

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-0.58%USD 25.83

BioArctic AB

BioArctic AB Valor: 38514501

Annual Return

-50%0%+50%

Risk level

110

-0.42%SEK 330.60

Zydus Lifesciences Limited

Zydus Lifesciences Limited Valor: 29835501

Annual Return

-50%0%+50%

Risk level

110

3.76%INR 1,141.00

Allogene Therapeutics Inc

Allogene Therapeutics Inc Valor: 43756548

Annual Return

-50%0%+50%

Risk level

110

-1.42%USD 2.08

Corcept Therapeutics Inc

Corcept Therapeutics Inc Valor: 1812837

Annual Return

-50%0%+50%

Risk level

110

1.96%USD 90.21

SIX

FactSet

Clearbit

Logos provided by Clearbit